StockTipsArenaBeta

BUY Natco Pharma Ltd — Ansh Jogendra Bhilwar

BUYNatco Pharma Ltd
Natco Pharma share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: Intraday26 Oct 2026, 8:00 am ISTvia Zee Business (Live)

Entry₹788.3Inferred
Target₹810
Total upside +2.75%
Stop loss₹783-0.67% risk
CMP₹790.35Just now
Active+0.26%+2.49%upside left 38m left
Follow Ansh Jogendra Bhilwar for new calls(14% target hit, 113 closed calls)Get alertsWatch NATCOPHARM for new buy/sell callsGet alertsSee 13 other Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 2:42 pm IST
2 supporting0 opposing
Supports the BUY call (2)

Natco Pharma launches Carboplatin injection in US market; shares rise 2%

NewsCnbc-Tv18·19 Oct · 6d ago

(opens in new tab)

Natco Pharma has launched a generic version of Carboplatin Injection in the U.S. market.

BSE · Company Update·19 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Natco Pharma

All analyst calls on Natco Pharma

More from Ansh Jogendra Bhilwar

Every call and its outcome